Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Completed · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies such as rituximab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Combining rituximab with combination chemotherapy may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining rituximab with combination chemotherapy in treating patients who have previously untreated non-Hodgkin's lymphoma.
Key facts
- Study ID
- NCT00032019
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 78
- Starts
- 2002-02-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2016-07-19
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
- Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center — Los Angeles, California, United States
- Naval Medical Center - San Diego — San Diego, California, United States
- Veterans Affairs Medical Center - San Diego — San Diego, California, United States
- UCSF Comprehensive Cancer Center — San Francisco, California, United States
- Veterans Affairs Medical Center - San Francisco — San Francisco, California, United States
- CCOP - Christiana Care Health Services — Newark, Delaware, United States
- Lombardi Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Washington, DC — Washington D.C., District of Columbia, United States
- Broward General Medical Center — Fort Lauderdale, Florida, United States
- Memorial Regional Hospital Comprehensive Cancer Center — Hollywood, Florida, United States
- CCOP - Mount Sinai Medical Center — Miami Beach, Florida, United States
- Florida Hospital Cancer Institute — Orlando, Florida, United States
- Palm Beach Cancer Institute — West Palm Beach, Florida, United States
- Veterans Affairs Medical Center - Chicago (Westside Hospital) — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Louis A. Weiss Memorial Hospital — Chicago, Illinois, United States
- CCOP - Illinois Oncology Research Association — Peoria, Illinois, United States
- West Suburban Center for Cancer Care — River Forest, Illinois, United States
- Saint Anthony Medical Center — Rockford, Illinois, United States
- Fort Wayne Medical Oncology and Hematology, Incorporated — Fort Wayne, Indiana, United States
- CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
- Hematology Oncology Associates of the Quad Cities — Bettendorf, Iowa, United States
- Northeast Alabama Regional Medical Center — Anniston, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.